# Suprachoroidal Administration in Subjects With Metastases to the Choroid

> **NCT06643884** · PHASE2 · RECRUITING · sponsor: **Aura Biosciences** · enrollment: 24 (estimated)

## Conditions studied

- Eye Cancer
- Primary Cancer

## Interventions

- **DRUG:** AU-011
- **DEVICE:** SCS Microinjector
- **DEVICE:** Laser

## Key facts

- **NCT ID:** NCT06643884
- **Lead sponsor:** Aura Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-10-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06643884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06643884, "Suprachoroidal Administration in Subjects With Metastases to the Choroid". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06643884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*